Carmen B Volkart

CIK 1282953 · Global Chief Financial Officer · last filed 2026-05-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.43M

Companies

6

Total Filings

50

Lifetime Open-Market Net

$332.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TCMD Director 44,219 $26.31 $1.16M $0 5 2026-05-08
MODD Director 806 $4.77 $3.8K $0 18 2026-04-08
ANTARES PHARMA, INC. (ATRS) Delisted Director $5.59 $0 1 2021-10-29
SONO Director 17,029 $15.36 $261.6K $0 7 2012-02-27
Wright Medical Group N.V. (TRNX) Delisted Global Chief Financial Officer 27,420 $332.5K 2 2011-05-13
MEMRY CORP (MRY) Delisted Director 21,905 $0 6 2008-04-03

Recent Filings · Page 2 of 5

50 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-05-10 TCMD Grant (A) +10,469 $0 EDGAR
2024-04-02 MODD Grant (A) +625 $0 EDGAR
2024-01-02 MODD Grant (A) +625 $0 EDGAR
2023-10-03 MODD Grant (A) +625 $0 EDGAR
2023-07-05 MODD Grant (A) +625 $0 EDGAR
2023-05-10 TCMD Grant (A) +7,737 $0 EDGAR
2023-04-03 MODD Grant (A) +625 $0 EDGAR
2023-02-24 TCMD Grant (A) +3,414 $0 EDGAR
2023-01-03 MODD Grant (A) +625 $0 EDGAR
2022-10-03 MODD Grant (A) +625 $0 EDGAR
Showing 1120 of 50
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.